NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Deep Blue Medical Advances

Deep Blue Medical Advances

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.deepbluemedical.com/

Last Round

Series A

Apr 21, 2026

Total Funding Raised

$21.82M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Deep Blue Medical Advances is a medical device company that develops and commercializes surgical products for hernia repair and other soft tissue surgeries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

hernia meshsurgical meshhernia repairsoft tissue repairsurgical fixationmedical devicemesh fixationsurgical scaffoldtissue control suturehernia recurrencesurgical failure preventionmesh hernia repairsurgical hardwareabdominal surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deep Blue Medical Advances Comparables

Compare Deep Blue Medical Advances with similar companies based on industry and business-model similarity.

Deep Blue Medical Advances comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Deep Blue Medical Advances Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 21, 2026
VC RoundSep 5, 2024
Series A ExtensionJun 28, 2022
Series AFeb 3, 2021
DebtJan 28, 2021
Debt
Aug 8, 2019

Key People

Founding team and executive leadership

Howie Levinson

Founder Chief Medical Officer

Founding Team

Bill Perry

CEO, Board Member

Executive Team

Deep Blue Medical Advances Investors

Notable investors and investment history

Deep Blue Medical Advances investors
InvestorRounds
BayMed Venture PartnersSeries A Extension
Triangle Angel PartnersSeries A
North Carolina Biotechnology CenterDebt, Grant
Wolfpack Investor NetworkVC Round
Band of AngelsSeries A
Harbright VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Raised $6M in Series A funding.

  • Apr 21, 2026

    Preparing for commercial launch of flagship soft tissue repair platform.

Deep Blue Medical Advances Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deep Blue Medical Advances Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deep Blue Medical Advances's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range11
Year Founded2015
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.